[{"Assets_0_Q3_USD":2509941000.0,"CommonStockSharesOutstanding_0_Q3_shares":48399097.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-94008000.0,"NetIncomeLoss_1_Q3_USD":32118000.0,"NetIncomeLoss_3_Q3_USD":-11946000.0,"StockholdersEquity_0_Q3_USD":1495282000.0,"EarningsPerShareBasic_1_Q3_USD":0.66,"EarningsPerShareBasic_3_Q3_USD":-0.25,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":48395000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":48329000.0,"Ticker":"LIVN","CIK":"1639691","name":"LIVANOVA PLC","OfficialName":"LivaNova PLC Ordinary Shares","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4559360993.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20191030"}]